Could a new drug help teens with ADHD?

NCT ID NCT07717892

Recruiting now Disease control Sponsor: Axsome Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests whether solriamfetol, a medication taken once daily, can reduce symptoms of attention deficit hyperactivity disorder (ADHD) in adolescents aged 12 to 18. Over six weeks, participants receive either solriamfetol or a placebo to compare changes in ADHD symptoms. The goal is to see if this drug is a safe and effective treatment option for teenagers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: solriamfetol capsules taken once daily
What this could lead to: If successful, this could provide a new medication option for managing ADHD symptoms in teenagers.
What could go wrong: This is a 6-week trial, so long-term effects and benefits are not yet known. The drug may not work better than placebo or could have side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHD

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clinical Research Site
RECRUITING

Dothan, Alabama, 36303, United States
Clinical Research Site
RECRUITING

Little Rock, Arkansas, 72211, United States
Clinical Research Site
RECRUITING

Coral Gables, Florida, 33146, United States
Clinical Research Site
RECRUITING

Jacksonville, Florida, 32256, United States
Clinical Research Site
RECRUITING

Maitland, Florida, 32751, United States
Clinical Research Site
RECRUITING

Orlando, Florida, 32801, United States
Clinical Research Site
RECRUITING

Bardstown, Kentucky, 40004, United States
Clinical Research Site
RECRUITING

Memphis, Tennessee, 38119, United States
Clinical Research Site
RECRUITING

Austin, Texas, 78759, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.